HIV-1 neutralizing antibodies and uses thereof Grant US-11944681-B2 United States of America 02 Apr 2024
Method for producing recombinant alkaline phosphatase Grant US-11913039-B2 United States of America 27 Feb 2024
Antibodies, variable domains and chains tailored for human use Grant US-11820810-B2 United States of America 21 Nov 2023
Hybrid cell lines for high level production of a target protein Grant US-11649449-B2 United States of America 16 May 2023
Methods of treating a subject with an alkaline phosphatase deficiency Grant US-11564978-B2 United States of America 31 Jan 2023
Vertebrate cells and methods for recombinantly expressing a polypeptide of interest Grant US-11512335-B2 United States of America 29 Nov 2022
PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED… Grant EP-3684381-B1 European Patent Office 02 Nov 2022
Methods for treating craniosynostosis in a patient Grant US-11400140-B2 United States of America 02 Aug 2022
HYDROGEN PEROXIDE EVOLVED HOST CELL Application WO-2022123519-A2 World Intellectual Property Organisation (WIPO) 16 Jun 2022
Transgenic non-human vertebrate for the expression of class-switched, fully human… Grant US-11297811-B2 United States of America 12 Apr 2022
Methods for treating hypophosphatasia (HPP) in adults and adolescents Grant US-11224637-B2 United States of America 18 Jan 2022
Treating seizure with recombinant alkaline phosphatase Grant US-11224638-B2 United States of America 18 Jan 2022
HIV-1 neutralizing antibodies and uses thereof Grant US-11071783-B2 United States of America 27 Jul 2021
Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics Grant US-11051497-B2 United States of America 06 Jul 2021
Engineered mammalian cells for production of recombinant proteins Grant US-10982191-B2 United States of America 20 Apr 2021
Antibodies, variable domains and chains tailored for human use Grant US-10730930-B2 United States of America 04 Aug 2020
Transgenic non-human vertebrate for the in vivo production of dual specificity… Grant US-10667501-B2 United States of America 02 Jun 2020
EXPRESSION SYSTEMS, RECOMBINANT CELLS AND USES THEREOF Application WO-2020084528-A1 World Intellectual Property Organisation (WIPO) 30 Apr 2020
Method of determining a compositional or functional characteristic of a cell culture media Grant US-10626436-B2 United States of America 21 Apr 2020
Long-term cell-cultivation using polyimide porous membrane and cell-cryopreservation… Grant US-10626365-B2 United States of America 21 Apr 2020
Method of predicting phenotypic instability in a cell Grant US-10591463-B2 United States of America 17 Mar 2020
HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies) Grant US-10450368-B2 United States of America 22 Oct 2019
Long-term cell-cultivation using polyimide porous membrane and cell-cryopreservation… Application US-10443037-B2 United States of America 15 Oct 2019
Mammalian cells expressing cytomegalovirus antigens Application US-10414802-B2 United States of America 17 Sep 2019
NOVEL VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST Application EP-3536776-A1 European Patent Office 11 Sep 2019
HIV-1 neutralizing antibodies and uses thereof (V3 antibodies) Grant US-10344077-B2 United States of America 09 Jul 2019
Cell lines for high level production of protein-based pharmaceuticals Application US-10329594-B1 United States of America 25 Jun 2019
Transgenic non-human vertebrate for the expression of class-switched, fully human… Grant US-10251377-B2 United States of America 09 Apr 2019
CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION Grant EP-2841561-B1 European Patent Office 16 Jan 2019
METHODS FOR IMPROVING CELL PROTEIN PRODUCTION YIELDS Application WO-2018229767-A1 World Intellectual Property Organisation (WIPO) 20 Dec 2018
Chimaeric surrogate light chains (SLC) comprising human VpreB Grant US-9963716-B2 United States of America 08 May 2018
Vector comprising gene fragment for enhancement of recombinant protein expression and use… Grant US-9902969-B2 United States of America 27 Feb 2018
Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein Grant US-9856462-B2 United States of America 02 Jan 2018
Antibodies, variable domains and chains tailored for human use Grant US-9783593-B2 United States of America 10 Oct 2017
Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics Grant US-9783618-B2 United States of America 10 Oct 2017
Glycosylated VEGF decoy receptor fusion protein Grant US-9777261-B2 United States of America 03 Oct 2017
VECTOR COMPRISING GENE FRAGMENT FOR ENHANCEMENT OF RECOMBINANT PROTEIN EXPRESSION AND USE… Application EP-3159411-A4 European Patent Office 07 Jun 2017
Synthetic promoter construct for transgene expression Grant US-9670497-B2 United States of America 06 Jun 2017
Transgenic mouse homozygous for chimeric IgH locus Grant US-9447177-B2 United States of America 20 Sep 2016
MAMMALIAN CELLS EXPRESSING CYTOMEGALOVIRUS ANTIGENS Application WO-2016067239-A1 World Intellectual Property Organisation (WIPO) 06 May 2016
Mammalian cells expressing cytomegalovirus antigens Application EP-3015475-A1 European Patent Office 04 May 2016
NOVEL VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST Application WO-2015166427-A3 World Intellectual Property Organisation (WIPO) 14 Jan 2016
VECTOR COMPRISING GENE FRAGMENT FOR ENHANCEMENT OF RECOMBINANT PROTEIN EXPRESSION AND USE… Application WO-2015194834-A1 World Intellectual Property Organisation (WIPO) 23 Dec 2015
MAMMALIAN CELL CULTURE Application WO-2013006479-A3 World Intellectual Property Organisation (WIPO) 28 Mar 2013